For CDI, fidaxomicin is preferred as first-line therapy for nonfulminant disease (oral vancomycin as acceptable alternative) www.cghjournal.org/article/S154... #OTILT @bwdionne.bsky.social @jeffpears0n.bsky.social @dannawang.bsky.social
AGA Clinical Practice Update on Management of Clostridioides difficile Infection in Adults: Expert Review
Clostridioides difficile infection is a common cause of clinically significant diarrhea, often becomes recurrent, and can be fatal when severe or fulminant. The purpose of this America Gastroenterological Association (AGA) Clinical Practice Update Expert Review is to provide best practice advice for C difficile infection management.
cghjournal.org